HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)

SHA:600829 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	663.44	1,235	1,100	1,314	1,181	800.49
Cash & Short-Term Investments	663.44	1,235	1,100	1,314	1,181	800.49
Cash Growth	6.96%	12.33%	-16.32%	11.25%	47.59%	91.18%
Accounts Receivable	4,766	4,086	4,350	4,385	4,168	4,182
Other Receivables	18.04	61.11	53.13	64.96	47.26	40.91
Receivables	4,784	4,147	4,403	4,450	4,215	4,222
Inventory	1,318	1,230	1,101	1,115	1,074	1,105
Prepaid Expenses	-	4.76	9.98	1.79	4.59	8.44
Other Current Assets	137.38	75.27	72.83	42.8	71.01	48.78
Total Current Assets	6,903	6,693	6,687	6,925	6,546	6,185
Property, Plant & Equipment	339	318.06	335.85	346.13	367.81	410.84
Other Intangible Assets	24.91	26.34	28.08	26.5	28.01	29.29
Long-Term Deferred Tax Assets	93.53	83.43	67.45	67.69	64.25	67.15
Long-Term Deferred Charges	6.98	8.93	10.48	11.2	11.81	12.08
Other Long-Term Assets	43.87	44.96	37.42	50.3	40.54	43.14
Total Assets	7,411	7,175	7,166	7,426	7,059	6,748

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2,947	2,836	2,781	2,914	2,614	2,478
Accrued Expenses	19.49	45.82	34.24	44.73	50.24	30.72
Short-Term Debt	639.4	679.4	839.22	962.08	1,198	1,233
Current Portion of Leases	28.24	24.89	30.56	27.69	32.09	35.18
Current Income Taxes Payable	39.54	26.96	25.84	43.33	27.38	34.92
Current Unearned Revenue	37.25	23.97	15.12	15.99	11.45	13.3
Other Current Liabilities	397.87	378.08	408.3	512.7	498.47	531.72
Total Current Liabilities	4,109	4,015	4,134	4,521	4,431	4,357
Long-Term Leases	34.56	28.08	30.37	29.41	38.48	59.59
Long-Term Unearned Revenue	110.56	113.63	117.09	120.94	125.71	130.77
Long-Term Deferred Tax Liabilities	5.47	3.31	3.7	4.05	4.51	-
Other Long-Term Liabilities	-	-	-	0.14	0.57	1.56
Total Liabilities	4,260	4,160	4,285	4,675	4,601	4,549

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	579.89	579.89	579.89	579.89	579.89	579.89
Retained Earnings	2,572	2,435	2,301	2,172	1,879	1,620
Total Common Equity	3,152	3,015	2,881	2,751	2,459	2,200
Minority Interest	-0.04	-0.04	-0.04	-0.04	-1.06	-1.02
Shareholders' Equity	3,152	3,015	2,881	2,751	2,458	2,199
Total Liabilities & Equity	7,411	7,175	7,166	7,426	7,059	6,748

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	702.2	732.37	900.15	1,019	1,268	1,328
Net Cash (Debt)	-38.77	503.04	199.69	295.17	-86.9	-527.08
Net Cash Growth	-	151.91%	-32.35%	-	-	-
Net Cash Per Share	-0.07	0.87	0.34	0.51	-0.15	-0.91
Filing Date Shares Outstanding	579.89	579.89	579.89	579.89	579.89	579.89
Total Common Shares Outstanding	579.89	579.89	579.89	579.89	579.89	579.89
Working Capital	2,794	2,678	2,553	2,404	2,115	1,829
Book Value Per Share	5.43	5.20	4.97	4.74	4.24	3.79
Tangible Book Value	3,127	2,989	2,853	2,725	2,431	2,171
Tangible Book Value Per Share	5.39	5.15	4.92	4.70	4.19	3.74
Buildings	-	357.93	372.04	372.04	374.91	374.93
Machinery	-	153.62	145.84	147.21	146.43	149.73
Construction In Progress	-	55.27	57.47	59.62	60.42	60.42

Data Source: S&P Global Market Intelligence Last updated: Oct 19, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error